Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
(2)
About
Gland Pharma Ltd.
NSE: GLAND
|
BSE: 543245
|
ISIN: INE068V01023
|
Industry: Pharmaceuticals
Policy Impact
|
Strong Performer, Getting Expensive
2197.6000
18.90
(
0.87
%)
NSE
Jun 17, 2026
15:31 PM
39.65% Gain from 52W Low
Volume:
847.4K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Gland Pharma Ltd.
04 Nov 2025
Policy Impact
2197.60
0.87%
Result Update:Gland Pharma
Hold:
Gland Pharma Ltd.
by
Axis Direct
Target: 2170 | Target met
Target
Axis Direct
We revise our rating from HOLD to BUY
Gland Pharma has gained
36.56%
in the last 3 Months
More from Gland Pharma Ltd.
Recommended
Stocks vs FD: has the extra risk been worth it?
The Baseline |
17 Jun 2026, 10:31PM
Market closes higher on lower oil prices and gains in PSU bank & defence stocks
Trendlyne Marketwatch |
17 Jun 2026, 04:02PM
Gland Pharma IPO: A Chinese-owned pharmaceutical company hits the IPO market
|
12 Nov 2020